Physical Evaluation of the Dental Patient - PowerPoint PPT Presentation

1 / 93
About This Presentation
Title:

Physical Evaluation of the Dental Patient

Description:

Title: No Slide Title Author: Dr. Nelson L. Rhodus Last modified by: Nelson Rhodus Created Date: 5/20/2002 3:28:58 PM Document presentation format – PowerPoint PPT presentation

Number of Views:120
Avg rating:3.0/5.0
Slides: 94
Provided by: DrNelson
Category:

less

Transcript and Presenter's Notes

Title: Physical Evaluation of the Dental Patient


1
Physical Evaluation of the Dental Patient
  • Dr. Nelson L. Rhodus
  • Diplomate, American Board of Oral Medicine
  • Morse Alumni Distinguished Professor
  • Director of Oral Medicine
  • University of Minnesota

2
6th edition 2002
3
Clinical laboratory testing
  • Relevant to dentistry
  • Indications
  • Signs and symptoms of disease
  • High risk groups
  • Confirm clinical diagnosis
  • Categories of lab tests
  • Diagnostic
  • Screening

4
THE DIAGNOSTIC PROCESS

CLINICAL EXAM
LABORATORY TESTS
HISTORY
ASSESSMENT
DIAGNOSIS
TREATMENT PLAN
5
Clinical laboratory testing
  • Lab tests used frequently by DDS
  • CBC( complete blood count)
  • Hemoglobin
  • Hematocrit
  • RBC, WBC
  • Differential WBC

6
Clinical laboratory testing
  • Lab tests used frequently by DDS
  • Bleeding studies
  • PT( INR) Prothrombin Time
  • PTT ( INR) Partial Thromboplastin Time
  • BT Bleeding time
  • Platelet count

7
Clinical laboratory testing
  • Lab tests used frequently by DDS
  • Fasting blood glucose ( 126 mg ) Hb A 1
    C
  • Infectious diseases HBV, HCV, HIV, other

8
Clinical laboratory testing
  • Lab tests used frequently by DDS
  • DDS should have a working concept of WNL( range)
  • Errors in testing
  • Clinical scenario MOST IMPORTANT!
  • May need to repeat test in light of clinical
    impression

9
Clinical laboratory testing
  • Lab tests used frequently by DDS
  • CBC RBC
  • 4.6 - 6.2 million /cc- male
  • 4.2 - 5.4 million/cc- female
  • ErythrocytopeniaDecrease Anemias Fe, B-12,
    folate, pernicious, sickle cell
  • Erythrocytosis Increase Polycythemia
    dehydration, infection-fever

10
Clinical laboratory testing
  • Lab tests used frequently by DDS
  • CBC Hemoglobin ( Hb)
  • Oxygen-carrying capacity
  • 13.5- 18.0 g/100cc - males
  • 11.5- 16.4 g/100cc - females

11
Clinical laboratory testing
  • Lab tests used frequently by DDS
  • CBC Hematocrit ( Hct)
  • Volume of RBCs per 100 cc of blood
  • 40 - 52 - males
  • 35- 47 - females

12
Clinical laboratory testing
  • Lab tests used frequently by DDS
  • CBC mean corpuscular hemoglobin ( MCH)
  • Average Hb content of each RBC
  • 27-32 pg

13
Clinical laboratory testing
  • Lab tests used frequently by DDS
  • CBC erythrocyte sedimentation rate ( ESR)
    aggregated RBCs
  • WNL lt 20 mm/hr.
  • Inflammation
  • Increase tissue destruction

14
Clinical laboratory testing
  • Lab tests used frequently by DDS
  • CBC WBC
  • 5,000 - 10,000 / cc
  • Leukocytosis increased WBC infection, RF,
    allergies, necrosis, exercise, pregnancy, stress,
    drugs, LEUKEMIA
  • Leukopenia decreased WBC hypovolemia, early
    leukemia, drugs, radiation, blood dyscrasias

15
Clinical laboratory testing
  • Lab tests used frequently by DDS
  • CBC differential WBC
  • Neutrophils( segmented) 50-70 Neutrophils(
    band) 0- 5
  • Lymphocytes 25-40
  • Monocytes 4-8
  • Eosinophils 1- 4
  • Basophils 0- 1

16
Clinical laboratory testing
  • Lab tests used frequently by DDS
  • CBC differential WBC
  • LEUKEMIAS
  • Acute lymphocytic( lymphoblastic) leukemia
  • Acute myelogenous leukemia
  • Chronic lymphocytic( lymphoblastic) leukemia
  • Chronic myelogenous leukemia

17
Clinical laboratory testing
  • Lab tests used frequently by DDS
  • CBC differential WBC
  • LYMPHOMAS
  • Hodgkins, non- Hodgkins, Burkitts

18
Clinical laboratory testing
  • Neutrophilic leukocytosis bacterial
    infections, inflammatory disorders, drug
    reactions, leukemia
  • Lymphocytosis bacterial infections, viral
    infections, leukemia
  • Eosinophilic leukocytosis allergic
    reactions

19
(No Transcript)
20
Clinical laboratory testing
  • BLOOD CHEMISTRY
  • SMA-12/60

21
(No Transcript)
22
Clinical laboratory testing
  • BLOOD CHEMISTRY
  • BONE METABOLISM
  • Calcium, Phosphorous, Alkaline phosphatase

23
(No Transcript)
24
Clinical laboratory testing
  • BLOOD CHEMISTRY
  • BONE METABOLISM
  • Calcium, Phosphorous, Alkaline phosphatase
  • Hyperparathyroidism, Multiple myeloma
  • Pagets disease, fibrous dysplasia
  • Osteoporosis , Cancer

25
(No Transcript)
26
Clinical laboratory testing
  • BLOOD CHEMISTRY
  • BONE METABOLISM
  • Calcium
  • 9.0-10.5 mg
  • Hypocalcemia hypoparathyroidism, Vit. D
    deficicency, preganancy, diuretics

27
Clinical laboratory testing
  • BLOOD CHEMISTRY
  • BONE METABOLISM
  • Phosphorus
  • 3.0- 4.5 mg
  • Hyperphosphatemia hypoparathyroidism, renal
    disease, hyperthyroidism, hypervitaminoisis D
  • Hypophosphatemia hyperparathyroidism,
    malabsorption, Vit. D deficiency

28
Clinical laboratory testing
  • BLOOD CHEMISTRY
  • BONE METABOLISM
  • Alkaline phosphatase
  • 25 - 115 Units/L
  • Elevated hyperparathyroidism, Pagets, sarcomas,
    metastatic carcinoma, growth

29
Clinical laboratory testing
  • BLOOD CHEMISTRY
  • RENAL FUNCTION TESTS
  • BUN ( blood urea nitrogen)
  • Uric Acid
  • Creatinine

30
Clinical laboratory testing
  • BLOOD CHEMISTRY
  • RENAL FUNCTION TESTS
  • BUN ( blood urea nitrogen)
  • 8-18 mg
  • Uric acid
  • 2.4-7.5 mg
  • Increased Chronic renal failure, chemo-Tx,
    lymphoproliferative disease, gout , acidosis

31
Clinical laboratory testing
  • BLOOD CHEMISTRY
  • RENAL FUNCTION TESTS
  • Creatinine
  • 0.6-1.2 mg
  • Increased Chronic renal failure, CHF,
    acromegaly, dehydration, diabetes, shock

32
Clinical laboratory testing
  • BLOOD CHEMISTRY
  • LIVER FUNCTION TESTS
  • LDH lactate dehydrogenase
  • AST aspartate aminotransferase
  • ALT alanine aminotransferase( SGPT)
  • Alkaline phosphatase
  • Bilirubin, Protein, Albumin

33
Clinical laboratory testing
  • BLOOD CHEMISTRY
  • LIVER FUNCTION TESTS
  • LDH lactate dehydrogenase
  • 50-240 Units/L
  • ALT
  • 0-40 Units/L

34
Clinical laboratory testing
  • BLOOD CHEMISTRY
  • LIVER FUNCTION TESTS
  • LDH and ALT increased
  • MI, liver disease, mononucleosis, renal disease,
    anemia, pancreatitis, skeletal muscle damage

35
Clinical laboratory testing
  • BLOOD CHEMISTRY
  • LIVER FUNCTION TESTS
  • Bilirubin
  • 02.-1.5 mg
  • liver disease hepatitis, cirrhosis, drug
    toxicities

36
Clinical laboratory testing
  • BLOOD CHEMISTRY
  • LIVER FUNCTION TESTS
  • Total protein
  • 5.6-8.4 g
  • Albumin 3.4- 5.4 g
  • Globulins 2.2-3.0 g
  • liver disease cirrhosis, chronic infections,
  • Multiple myeloma

37
Clinical laboratory testing
  • BLOOD CHEMISTRY
  • BLOOD GLUCOSE
  • 70-100 mg
  • Fasting gt 126 mg diabetes
  • Increased corticosteroids, catecholamines,
    growth hormone, CHF, diuretics

38
Clinical laboratory testing
  • BLOOD CHEMISTRY
  • SERUM CHOLESTEROL
  • lt200 mg
  • Elevated hypercholesterolemia risk for ASCVD(
    MI)

39
(No Transcript)
40
Normal control of bleeding
  • Vascular phase
  • Platelet phase
  • Coagulation phase

41
bleeding problems
  • Inherited
  • Acquired
  • Drug therapy

42
Detection of the patient with bleeding problems
  • Prothrombin time( PT ) or International
    Normalized Ratio (INR)
  • Partial thromboplastin time (PTT)
  • Thrombin time (TT)
  • Bleeding time (BT)
  • Platelet count

43
Prothrombin time (PT)
  • activated by tissue thromboplastin tests
    extrinsic and common pathways
  • run with a control ( variable with lab
    therefore INR)
  • normal 11-15 seconds
  • prolonged time abnormal ( significant for
    dentistry gt 2.5, 3.0, 3.5...)

44
Activated partial thromboplastin time (PTT)
  • Contact activator( kaolin)
  • tests the intrinsic and common pathways
  • run with a control
  • normal 25-35 seconds
  • prolonged ( 2.5, 3.0, 3.5...) abnormal

45
Thrombin time(TT)
  • activated by thrombin
  • tests the ability to form a solid clot
  • run with a control
  • normal 9-13 seconds
  • prolonged( 2.5, 3.0, 3.5,...) abnormal

46
Ivy bleeding time (IBT)
  • tests vascular and platelet status
  • Immediate factors in control of bleeding
  • normal 1-6 minutes
  • abnormal prolonged time

47
(No Transcript)
48
(No Transcript)
49
Platelet count
  • tests numbers of platelets present to form clot
  • normal 140,000 to 400,000 / cc
  • bleeding problems lt 50,000/cc

50
Thrombocytopenia
  • platelet count 50,000 ( with or without
    platelet replacement)
  • lt 50,000 bleeding problem

51
Bleeding disorders
  • Nonthrombocytopenic purpuras
  • vascular wall alterations
  • platelet function disorder
  • Thrombocytopenic purpuras
  • Primary ( genetic)
  • secondary( acquired drugs, diseases)
  • Disorders of coagulation
  • inherited, acquired

52
Microbiological exam
  • Sample collection ( bacterial, fungal, etc.)
  • Lesion
  • Transport media
  • Clinical information site, nature, differential
    diagnosis
  • ID organism
  • Antimicrobial sensitivity long-term Rx,
    diabetes, immunosuppressed, refractory to Tx
  • Closely follow course of TX

53
Diabetes mellitus Detection and management
  • Dr. Nelson L. Rhodus
  • Director of Oral Medicine
  • University of Minnesota

54
cellulitis
55
incision and drainage
56
Antibiotic culture and sensivitiy testing
57
Cytology
  • Exfoliative cytology ( Oral CDx) brush
    biopsy.. PAP smear
  • Scrape off surface of lesion to BM if possible
  • Useful for HSV, Candidiasis, pemphigus, some
    bacteria, cellular atypia

58
(No Transcript)
59
(No Transcript)
60
(No Transcript)
61
Exfoliative cytology
  • Oral CDx ( brush biopsy)
  • some, limited clinical diagnostic value( decide
    to Bx)
  • irregular epilthelial cells (not flat)
  • enlarged, irregular size and shape of nuclei
  • hyperchromatic nuclei

62
(No Transcript)
63
ORAL CANCERDETECTION
  • CLINICAL vs. DEFINITIVE DIAGNOSIS
  • HISTOPATHOLOGY ..MUST !!
  • lesion with MODERATE DEGREE of clinical
    suspicion ...BIOPSY
  • lesion with HIGH DEGREE of clinical
    suspicion...REFER

64
(No Transcript)
65
(No Transcript)
66
Leukoplakia to SCCA
  • mean age 63 F M
  • time to transformation 7.2 years
  • precedent dysplasia 17
  • 17 WITH Bx-proven dysplasia gtgtgt SCCA in 3 yrs.

67
Biopsy
  • Excisional- entire lesion is removed
  • Incisional- portion of large lesion
  • Punch
  • Fine-needle aspiration
  • Oral pathologist
  • Clinical information to pathologist

68
(No Transcript)
69
(No Transcript)
70
(No Transcript)
71
(No Transcript)
72
(No Transcript)
73
(No Transcript)
74
(No Transcript)
75
(No Transcript)
76
Toludine blue
  • Ora-scan
  • binds to DNA
  • 93 accurate adjunct
  • uptake high yield margins
  • false ves

77
(No Transcript)
78
(No Transcript)
79
Candida species
  • several common species in oral cavity
  • Candida may proliferate with immunosuppression
  • increase in Candida counts with decreased
    salivary flow
  • associated with diabetes, hematologic
    abnormalities and several other disorders
    including Sjogrens syndrome

80
(No Transcript)
81
(No Transcript)
82
(No Transcript)
83
Diascopy
  • Detects blood in a blisterform lesion
  • Press on lesion with a glass microscope slide
  • If color blanches blood-filled
  • Oxidized vs. reduced blood

84
(No Transcript)
85
FNA
  • salivary glands
  • lymph nodes
  • 22 gauge needle 10 - 20 ml syringe
  • cytology

86
(No Transcript)
87
(No Transcript)
88
MRI of pleomorphic adenoma of the right parotid
gland
89
Asdvanced laboratory techniques
  • DNA testing( microarray, RT-pcr, etc.)
  • Cytogenetics, chromosomal
  • Viral testing
  • ELISA, enzyme assays
  • Immunofluorescence
  • Antibodies
  • Salivary scintigraphy
  • MRI, CT , etc.

90
p53 distribution in LP
91
(No Transcript)
92
(No Transcript)
93
Candidiasis
  • 53 in SCCA 31 in WNL
  • chronic fungi epithelial adhesion
  • immunoincompetence
  • higher correlation with leukoplakias to SCCA
    transformation (61)
Write a Comment
User Comments (0)
About PowerShow.com